Recommended Free Tools
India’s National Medical Commission (NMC) listed new guidelines on ethical advertising and public communication on 6 October 2026. They cover hospitals, medical institutions and registered medical practitioners, with reported provisions addressing social-media promotion, patient reviews, AI-generated campaigns and patient privacy. The notice confirms the guidelines’ listing and date; details below are attributed to contemporaneous reporting because the linked official PDF’s text was not extractable for verification.
What the NMC announcement covers
The NMC’s official notice and linked guideline list the document under the title “Guidelines on Ethical Advertising and Public Communication by Hospitals/Medical Institutions and Registered Medical Practitioners.” The notice is dated 6 October 2026. Reporting describes the rules as applying to promotion in traditional and digital channels, including social media, websites, messaging channels, sponsored posts and influencer marketing. Communications promoting a practitioner’s or institution’s services, reputation, qualifications, achievements or facilities may fall within that advertising framework.
The reported restrictions are not limited to Instagram. They concern professional promotion wherever it appears, including when an intermediary or AI-generated material is involved.
As an Amazon Associate I earn from qualifying purchases.
Can doctors post patient reviews on Instagram?
South First reports that the guideline says: “A Registered Medical Practitioner shall not request or share patient testimonials, recommendations, endorsements or reviews for professional promotion on social media.” The report also describes a prohibition on soliciting, purchasing, procuring, manipulating or publishing fake, paid or misleading reviews, ratings, testimonials, endorsements or recommendations to promote medical services.
The reported wording focuses on professional promotion and specified conduct. It does not establish that every neutral patient comment, wherever it appears, is automatically a violation. The practical distinction is between a patient speaking independently and a practitioner requesting or sharing feedback to promote a service.
What the reported rules say about AI promotions
Medical Dialogues reports that AI-generated promotional campaigns serving commercial interests are prohibited. It says otherwise compliant AI-generated promotional content must be marked to state explicitly that it originated from AI. South First also reports that AI may not be used to create or alter a patient’s image, testimonial or clinical outcome for promotion.
This is not reported as a blanket ban on AI. Medical Dialogues describes an exception for separate government public-interest campaigns, and says permitted AI-generated promotional material must carry an origin mark. The reports do not establish that all AI-assisted public-health communication is prohibited.
Patient images, privacy and consent
Posting a patient’s face is not the only way to make someone identifiable: a name, unusual condition or combination of details can also reveal identity. South First reports that the new guidance cautions against sharing patient information or clinical images in ways that identify patients unnecessarily, and says legally required consent should be specific, informed, voluntary, documented and verifiable. Medical Dialogues describes safeguards such as cropping, blurring or blacking out identifying details where disclosure is lawfully permitted.
The existing NMC Code of Medical Ethics Regulations, 2002 already restricts disclosure of patient secrets, subject to specified circumstances, and requires permission for identifiable patient photographs or case reports. A public post therefore raises privacy and professional-ethics questions even when its purpose is educational.
Other reported limits on healthcare promotion
Claims about being “best” or “No.1”
Medical Dialogues reports that comparative claims such as “best,” “No.1,” “leading” or “most trusted” are restricted unless they can be objectively verified through a transparent and independently ascertainable method. The distinction is between a substantiated, checkable claim and an unsupported assertion of superiority.
Referral fees and patient leads
The same report says the guidelines prohibit commissions, rebates, referral fees, lead-generation fees or other consideration linked to referring or procuring patients. This restriction reaches arrangements that use online promotion or intermediaries to channel patients for payment.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteOffers, incentives and influencers
Medical Dialogues reports restrictions on discounts, limited-period offers, contests, coupons, gifts, cashbacks, referral benefits or free procedures when they are likely to encourage unnecessary consultation, diagnosis or treatment, or otherwise solicit patients. It also describes limits on influencers and other third parties doing indirectly what a doctor or institution cannot do directly.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.How the new guidance relates to the 2002 ethics code
The NMC’s 2002 code already treats direct or indirect patient solicitation and publicity likely to draw attention to a physician’s skill, achievements or professional position as unethical. It also bars a physician from endorsing a drug, remedy, therapeutic article or commercial product in advertising. At the same time, it permits certain formal practice announcements and public communication on public health and hygienic living, provided the communication does not become advertising or solicitation.
The central boundary is therefore not simply whether a doctor speaks in public. It is whether communication provides factual or public-health information or instead promotes professional services, solicits patients or makes commercial claims.
What is established about timing and enforcement
The NMC notice establishes that the guideline was listed on 6 October 2026. South First reports that it took effect immediately and describes suspension or removal from the medical register for serious or repeated violations, with procedural safeguards and appeal information. Those enforcement details, including the precise penalty range, decision-maker and appeal deadlines, could not be verified from extractable text of the official PDF, so they should be checked against the original document before being treated as definitive. Reporting also notes that hospitals may be subject to the clinical-establishment law applicable in their jurisdiction.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
